IXICO PLC  

(Public, LON:IXI)   Watch this stock  
Find more results for Charles Lowther�
35.12
+1.12 (3.29%)
Jul 30 - Close
LON real-time data - Disclaimer
Currency in GBX unless noted
Range     -
52 week 0.21 - 0.52
Open 34.00
Vol / Avg. 0.00/29,652.00
Mkt cap 5.12M*
P/E     -
Div/yield     -
EPS     -
Shares 15.06M
Beta     -
Inst. own     -
*GBP
Jun 15, 2015
IXICO PLC at Biotechnology Industry Organization (BIO) International Convention
May 18, 2015
Half Year 2015 IXICO PLC Earnings Release
  

Key stats and ratios

Q1 (Mar '15) 2014
Net profit margin -39.01% -
Operating margin -48.25% -
EBITD margin - -
Return on average assets -24.87% -
Return on average equity -35.35% -
Employees 52 -
CDP Score - -

Address

4th Floor, 15 Long Lane, Griffin Court
LONDON, EC1A 9PN
United Kingdom - Map
+44-20-37637499 (Phone)
+44-20-72092473 (Fax)

Website links

External links

Analyst Estimates - BusinessWeek
Options - MarketWatch
Director Dealings - Yahoo Finance

Description

IXICO plc is engaged in the provision of clinical trials services to the pharmaceutical industry. The Company provides its technologies to those involved in researching and treating diseases, such as dementia. The Company's digital health technology consists of three product platforms, which include TrialTracker, Assessa and MyBrainBook. Its TrialTracker image data and query management platform serves its clinical trials business. TrialTracker is used in clinical trials run by IXICO and forms the framework for its medical device, Assessa. The Company's Assessa is its decision support tool for diagnosing dementia and Alzheimer's disease. Assessa is also used in other neurological disorders in which the measurement of hippocampal volume can be used, such as schizophrenia. Its MyBrainBook provides support to dementia patients post-diagnosis. MyBrainBook is a digital health hub delivering facilitated support to patients and their carers.

Officers and directors

Derek Hill Ph.D. Chief Executive Officer, Director
Susan Day Lowther Chief Financial Officer
Age: 54
Michelle Lax Vice President - Clinical Operations
Charles Spicer Vice President - Corporate Development, Director
Age: 48
Jane Whitrow Secretary
Andy Richards Non-Executive Chairman of the Board
Maina Bhaman MBA Non-Executive Director
John Bradshaw Non-Executive Director
Tim Sharpington Senior Non-Executive Independent Director